Matches in Nanopublications for { ?s ?p "[We report a novel heterozygous 40 base pair deletion in exon 3 of the parkin gene that increases the susceptibility of carriers to develop parkinsonism/dystonia and manifests variability in regard to age of onset and phenotype in a single family.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP140767.RAm30Bof78rMTp2VupDYnH16CaqGWGZpSRHZuPNf3-fAU130_assertion description "[We report a novel heterozygous 40 base pair deletion in exon 3 of the parkin gene that increases the susceptibility of carriers to develop parkinsonism/dystonia and manifests variability in regard to age of onset and phenotype in a single family.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140767.RAm30Bof78rMTp2VupDYnH16CaqGWGZpSRHZuPNf3-fAU130_provenance.
- NP111012.RA-ZmTl5ISH0l1JAerhZTSVCM-6jgazHRFn3LTDiGzPtc130_assertion description "[We report a novel heterozygous 40 base pair deletion in exon 3 of the parkin gene that increases the susceptibility of carriers to develop parkinsonism/dystonia and manifests variability in regard to age of onset and phenotype in a single family.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111012.RA-ZmTl5ISH0l1JAerhZTSVCM-6jgazHRFn3LTDiGzPtc130_provenance.
- NP203911.RAeEIFrXSfqVLmrDVgcwM-DZHzfJOIww2eQAEy_W_OOWY130_assertion description "[We report a novel heterozygous 40 base pair deletion in exon 3 of the parkin gene that increases the susceptibility of carriers to develop parkinsonism/dystonia and manifests variability in regard to age of onset and phenotype in a single family.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203911.RAeEIFrXSfqVLmrDVgcwM-DZHzfJOIww2eQAEy_W_OOWY130_provenance.
- NP200177.RADoeDUzCxRh4w7oHDihYrH3XI6l-_bVZEz71rAG7ELjg130_assertion description "[We report a novel heterozygous 40 base pair deletion in exon 3 of the parkin gene that increases the susceptibility of carriers to develop parkinsonism/dystonia and manifests variability in regard to age of onset and phenotype in a single family.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP200177.RADoeDUzCxRh4w7oHDihYrH3XI6l-_bVZEz71rAG7ELjg130_provenance.
- NP200176.RA5cYzX44uvzcv0tRAjOpigG_FEB5g5cKwJiO1AwzsEiA130_assertion description "[We report a novel heterozygous 40 base pair deletion in exon 3 of the parkin gene that increases the susceptibility of carriers to develop parkinsonism/dystonia and manifests variability in regard to age of onset and phenotype in a single family.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP200176.RA5cYzX44uvzcv0tRAjOpigG_FEB5g5cKwJiO1AwzsEiA130_provenance.
- assertion description "[We report a novel heterozygous 40 base pair deletion in exon 3 of the parkin gene that increases the susceptibility of carriers to develop parkinsonism/dystonia and manifests variability in regard to age of onset and phenotype in a single family.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We report a novel heterozygous 40 base pair deletion in exon 3 of the parkin gene that increases the susceptibility of carriers to develop parkinsonism/dystonia and manifests variability in regard to age of onset and phenotype in a single family.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP174224.RAipj1O8VaQnTf7-OHIh1lnsMeiMsQMxTRYZyv4R6HD5c130_assertion description "[We report a novel heterozygous 40 base pair deletion in exon 3 of the parkin gene that increases the susceptibility of carriers to develop parkinsonism/dystonia and manifests variability in regard to age of onset and phenotype in a single family.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174224.RAipj1O8VaQnTf7-OHIh1lnsMeiMsQMxTRYZyv4R6HD5c130_provenance.